APA Style
Abdulaziz Alhossan. (2025). Preface. Clinical Pharmacy Connect, 1 (Article ID: 0007). https://doi.org/10.69709/CPC.2025.113760MLA Style
Abdulaziz Alhossan. "Preface". Clinical Pharmacy Connect, vol. 1, 2025, Article ID: 0007, https://doi.org/10.69709/CPC.2025.113760.Chicago Style
Abdulaziz Alhossan. 2025. "Preface." Clinical Pharmacy Connect 1 (2025): 0007. https://doi.org/10.69709/CPC.2025.113760.
ACCESS
Editorial
Volume 1, Article ID: 2025.0007
Abdulaziz Alhossan
alhossan@ksu.edu.sa
King Saud University, Riyadh, Saudi Arabia
Received: 20 Dec 2025 Published: 25 Dec 2025
Welcome to the inaugural volume of the Clinical Pharmacy Connect Journal, a peer-reviewed journal that aims to publish original, high-quality research, reviews, and communications on the latest developments in all areas of pharmacy practice. The rapid advancements in clinical pharmacy have necessitated a dedicated platform for scholarly exchange, rigorous peer review, and the dissemination of innovative research. We have assembled a diverse editorial board, and we are committed to a fast, fair, and thorough peer-review process. We are grateful to the editorial board members for their invaluable guidance in shaping this publication and to the authors who trusted us with their research. Our mission is to foster rigorous, impactful research addressing patient care and health outcomes in clinical pharmacy. We invite you to contribute your innovative work and join us in shaping the future of clinical pharmacy. In Volume 1, we are pleased to present four articles spanning different types of scholarly contributions, including an editorial, one research article, a systematic review, and a review article. 1. Clinical Pharmacy at the Crossroads: Advancing Care, Improving Outcomes—Editorial by Anan Jarab In this editorial, Anan Jarab discusses the evolution of clinical pharmacy from a dispensing-focused profession to a patient-centered discipline, highlighting innovation, future opportunities, and the role of Clinical Pharmacy Connect in advancing the field. 2. Descriptive Analysis of Reported Adverse Events Associated with Metoclopramide Using FDA Adverse Event Reporting System Databases—Research Article by Nehad Jaser Ahmed In this study, Nehad Jaser Ahmed presents a descriptive analysis of adverse events associated with metoclopramide using the FDA Adverse Event Reporting System (FAERS), highlighting the predominance of neurological complications and emphasizing the importance of vigilant pharmacovigilance in clinical practice. 3. The Role of Pharmacists in Public Health and Disease Prevention: What Do We Know?—Review Article by Ahmad Z. Al Meslamani In this review, Ahmad Z. Al Meslamani examines the expanding role of pharmacists in public health and disease prevention, synthesizing global evidence across preventive, diagnostic, therapeutic, and digital domains while highlighting policy and structural barriers that limit the full integration of pharmacists into population health strategies. 4. Efficacy of Monoclonal Antibodies for Malaria Prevention: A Meta-Analysis—Systematic Review by Nehad Jaser Ahmed In this meta-analysis, Nehad Jaser Ahmed evaluates the efficacy of monoclonal antibodies for malaria prevention, demonstrating significant protective effects against Plasmodium falciparum while addressing considerations related to population variability, cost, and scalability.
Disclaimer/Publisher’s Note: The views expressed in this article are those of the author(s) and do not necessarily reflect the views of the publisher or editors. The publisher and editors assume no responsibility for any injury or damage resulting from the use of information contained herein.
©2025 Copyright by the Authors.
Licensed as an open-access article distributed under the terms and conditions of the CC BY 4.0 license
We use cookies to improve your experience on our site. By continuing to use our site, you accept our use of cookies. Learn more